Pseudohypoparathyroidism historical perspective: Difference between revisions
Jump to navigation
Jump to search
Mazia Fatima (talk | contribs) |
Mazia Fatima (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim and associated clinical features of Albright hereditary osteodystrophy. | |||
==Historical Perspective== | ==Historical Perspective== | ||
Revision as of 19:06, 28 September 2017
|
Pseudohypoparathyroidism Microchapters |
|
Differentiating Pseudohypoparathyroidism from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pseudohypoparathyroidism historical perspective On the Web |
|
American Roentgen Ray Society Images of Pseudohypoparathyroidism historical perspective |
|
Risk calculators and risk factors for Pseudohypoparathyroidism historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim and associated clinical features of Albright hereditary osteodystrophy.
Historical Perspective
- In 1942, Fuller albright, an American endocrinologist, first discovered pseudohypoparathyroidim. Pseudohypoparathyoroidism is the first hormone resistance syndrome to be discovered.[1]
- In the same year, Albright hereditary osteodystrophy was clinically described together with pseudohypoparathyroidism. [2]